Hyperbaric Oxygen Therapy in HAMstring Injury (HOTHAM) Trial

Brief Summary

Detailed Description

Trial objectives and endpoints Primary objective(s) Endpoint for the primary objective To Compare the time needed to return to play (RTP) or -full unrestricted duty (RTD) after seven daily sessions of HBOT to a historical control group (standard care). • Time needed to return to play (days) / time needed to return to full unrestricted duty (days) defined as: * RTP: Number of days from initial injury until the athlete is cleared to resume full unrestricted training * RTP: Number of days from initial injury until soldier is cleared to resume full unrestricted (physical) duty activities. Secondary objective(s), if applicable Endpoint(s) for secondary objectives Clinically assess the hamstring injury over time (Baseline, week 2 and at RTP/RTD) • Patient reported hamstring scores: Tenger activity score, Functional Assessment scale for acute hamstring injuries and psychological readiness. * Maximum and mean pain scores (0-10) assessed with the visual analog scale, at injury, at rest and during sprinting. * Physical examination including: * Palpation: Location and dimension of painful area/lesion, presence of hematoma or -swelling * Pain with isometric contraction against resistance * Hamstring flexibility tests: Passive straight leg raise, Active knee extension test. * Hamstring isokinetic strength (Hand hold dynamometer) Investigate MRI changes over time (Baseline, week 2) * MRI derived parameters: Aspect of the injury on T1 and T2-weighted images scored by a radiologist using a standardized form. Registration of re-injury rates at 2- and 12 months following initial injury • Number of re-injury at -2 and 12 months following initial injury Assess safety of HBOT in patients with hamstring injury • Number of AE- and SAE from signing of informed consent to 1 week following last HBOT session. Trial design Open-label, prospective study with matched historical control cases as comparators (case-control) where participants are treated with seven daily sessions of hyperbaric oxygen therapy followed by one year of electronic follow-up. Trial population The trial population will consist of 50 adult (≥18 years old) athletes and military personnel with a recent (≤7 days) clinical diagnosis of an acute hamstring injury, defined as: * Anamnestic acute injury * Anamnestic pain in the posterior thigh * Localized pain during palpation of the hamstring muscle * Localized pain during passive straight leg raise * Increased pain during isometric contraction of the hamstring muscles. Participants will not be eligible to participate in the study if they: are not capable of doing an active exercise program, have no intention to return to full sporting or duty activities, the injury is caused by extrinsic trauma, they have a chronic or recent (\<2 months) hamstring injury, the injury is a complete proximal tendon avulsion, there are other injuries inhibiting recovery or if there are contra-indications for MRI or HBOT. Interventions: Following inclusion patients will be treated with seven daily sessions of HBOT. During this treatment patients are placed in a hyperbaric chamber in which 100% (pure) medicinal oxygen is breathed via a built-in breathing mask at a pressure of 2.4 times atmospheric pressure (equal to diving at a depth of 14 meters) for 90 min, including three 5 min 'air breaks' during which patients breathe air instead of oxygen. This treatment regime is standard within the AUMC and thus remains within the oxygen toxicity and non-decompression limits. . On three occasions (baseline and week 2 and at RTP/RTD) participants will undergo physical examination. On two occasions (baseline and week 2) an MRI scan of the injured leg will be made. Participants will be monitored for the occurrence of re-injury at 2 and 12 months following return to sport or -unrestricted duty

Primary Outcomes

Secondary Outcomes

• Clinical assessment(Baseline, week 2 and at return to full restricted play/-duty (assessed up to 1 year following injury))
• Radiologic assessment(Baseline and week 2)
• Adverse events(Baseline up until 1 week following last treatment session.)
• Re-injury registration(2- and 12 months following injury)